David Grainger

FAQ About David Grainger

• What is David Grainger's address?

  David Grainger is located at
  Cambridge, Cambridge, United Kingdom

• What is David Grainger's job title?

  David Grainger is a
  I develop exciting new drugs, with novel mechanisms of action, challenging conventional wisdom on how drugs should be developed at every step. I am now Chief Innovation Officer at Centessa Pharmaceuticals (NASDAQ: CNTA), overseeing the research across our pipeline of 16 programs, which range from discovery to Ph3 clinical trials. I was Founding General Partner at Medicxi, one if Europe's largest and most successful Life Sciences Venture Capital groups, where I have acted as Chief Scientific Advisor since 2017 and am currently a Venture Advisor. I am currently a Director of more than a dozen biotech companies in the UK and US. Previously, I acted as CSO at XO1, developing an anticoagulant antibody. XO1 was sold to Janssen in March 2015, and also CSO at Funxional Therapeutics, a company developing novel small molecule anti-inflammatory agents sold to Boehringer Ingelheim in 2012, as well as CEO at Methuselah Health Inc, a company engaged in healthy ageing R&D. I also currently act as Executive Chairman at RxCelerate, a rapidly-growing out-sourced drug developer, with offices in the UK & US, which I founded in 2013 alongside Dr Jill Reckless.RxCelerate offers a turn-key drug discovery and development service, with expertise in both small-molecules and biologics through our proprietary Galaxy platform. Until 2011, I was an academic, based in Department of Medicine, Cambridge University, UK, where I led a group of about 10 scientists investigating the molecular mechanisms responsible for chronic inflammation in health and disease. I have published more than 70 primary publications, many in leading journals including Science, Nature and Nature Medicine. My career goal is to successfully integrate deep technical knowledge and a keen commercial perspective to ensure that the highest quality cutting edge research is effectively exploited to bring genuine healthcare benefits to the wider community. Specialties: In addition to technical expertise in drug discovery and early stage development (including US regulatory pathways to IND for therapeutics and 510(k) for diagnostics), I also have extensive experience in intellectual property management and strategy, as well drafting individual patent applications. I have been responsible for in- and out-licensing of healthcare technologies, for significant venture capital financing of several companies and for several mergers and acquisitions. Centessa Pharmaceuticals

• What industry does David Grainger currently work in?

  David Grainger currently works in the
  Centessa Pharmaceuticals

• What is David Grainger's area of expertise?

  David Grainger specializes in
  I develop exciting new drugs, with novel mechanisms of action, challenging conventional wisdom on how drugs should be developed at every step. I am now Chief Innovation Officer at Centessa Pharmaceuticals (NASDAQ: CNTA), overseeing the research across our pipeline of 16 programs, which range from discovery to Ph3 clinical trials. I was Founding General Partner at Medicxi, one if Europe's largest and most successful Life Sciences Venture Capital groups, where I have acted as Chief Scientific Advisor since 2017 and am currently a Venture Advisor. I am currently a Director of more than a dozen biotech companies in the UK and US. Previously, I acted as CSO at XO1, developing an anticoagulant antibody. XO1 was sold to Janssen in March 2015, and also CSO at Funxional Therapeutics, a company developing novel small molecule anti-inflammatory agents sold to Boehringer Ingelheim in 2012, as well as CEO at Methuselah Health Inc, a company engaged in healthy ageing R&D. I also currently act as Executive Chairman at RxCelerate, a rapidly-growing out-sourced drug developer, with offices in the UK & US, which I founded in 2013 alongside Dr Jill Reckless.RxCelerate offers a turn-key drug discovery and development service, with expertise in both small-molecules and biologics through our proprietary Galaxy platform. Until 2011, I was an academic, based in Department of Medicine, Cambridge University, UK, where I led a group of about 10 scientists investigating the molecular mechanisms responsible for chronic inflammation in health and disease. I have published more than 70 primary publications, many in leading journals including Science, Nature and Nature Medicine. My career goal is to successfully integrate deep technical knowledge and a keen commercial perspective to ensure that the highest quality cutting edge research is effectively exploited to bring genuine healthcare benefits to the wider community. Specialties: In addition to technical expertise in drug discovery and early stage development (including US regulatory pathways to IND for therapeutics and 510(k) for diagnostics), I also have extensive experience in intellectual property management and strategy, as well drafting individual patent applications. I have been responsible for in- and out-licensing of healthcare technologies, for significant venture capital financing of several companies and for several mergers and acquisitions.

• Which languages does David Grainger speak? 

  David Grainger speaks the following languages:
  No languages available.

• Which industries has David Grainger previously worked in?   

  David Grainger has prior experience in the following industries:
  Centessa Pharmaceuticals , Xo1 , Total Scientific , Index Ventures , Pronostics , Funxional Therapeutics , Tcp Innovations , Cambridge University

• What is David Grainger’s work experience?  

  David Grainger has the following professional experience:
  Centessa Pharmaceuticals , Medicxi , Rxcelerate , Xo1 , Total Scientific , Index Ventures , Pronostics , Funxional Therapeutics , Tcp Innovations , Cambridge University .

• How can I find David Grainger on LinkedIn?  

  You can view David Grainger’s
  LinkedIn profile at LinkedIn URL.

• What are David Grainger’s work email addresses?  

  David Grainger’s work email addresses are
  [email protected] .

• What company does David Grainger work for?  

  David Grainger works at
  Centessa Pharmaceuticals